Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Plos Genetics|June 27, 2014
ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistanceZhiqiang Wang, Zheng Liu, Xiwei Wu, et al.
Ejhaem|May 7, 2025
Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid LeukemiaKendall Diebold, Devan Parker, Sarah Worth, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
Blood|September 18, 2013
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferationPaolo Gallipoli, Francesca Pellicano, Heather Morrison, et al.
ACS Physical Chemistry Au|March 1, 2023
Fano-Type Wavelength-Dependent Asymmetric Raman Line Shapes from MoS<sub>2</sub> NanoflakesManushree Tanwar, Love Bansal, Chanchal Rani, et al.
Blood|June 25, 2014
JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivoPaolo Gallipoli, Amy Cook, Susan Rhodes, et al.
Cell Death & Disease|August 27, 2024
CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulatorLixia Zhang, Xinyue Zhou, Sajesan Aryal, et al.
Blood|March 27, 2014
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cellsAmy M Cook, Liang Li, Yinwei Ho, et al.
Bone Marrow Transplantation|January 9, 2021
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantationOmer Jamy, Alice Chen, Kevin Battles, et al.
Blood|March 20, 2008
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cellsAnna Scuto, Mark Kirschbaum, Claudia Kowolik, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Plos Genetics|June 27, 2014
ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistanceZhiqiang Wang, Zheng Liu, Xiwei Wu, et al.
Ejhaem|May 7, 2025
Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid LeukemiaKendall Diebold, Devan Parker, Sarah Worth, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
Blood|September 18, 2013
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferationPaolo Gallipoli, Francesca Pellicano, Heather Morrison, et al.
ACS Physical Chemistry Au|March 1, 2023
Fano-Type Wavelength-Dependent Asymmetric Raman Line Shapes from MoS<sub>2</sub> NanoflakesManushree Tanwar, Love Bansal, Chanchal Rani, et al.
Blood|June 25, 2014
JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivoPaolo Gallipoli, Amy Cook, Susan Rhodes, et al.
Cell Death & Disease|August 27, 2024
CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulatorLixia Zhang, Xinyue Zhou, Sajesan Aryal, et al.
Blood|March 27, 2014
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cellsAmy M Cook, Liang Li, Yinwei Ho, et al.
Bone Marrow Transplantation|January 9, 2021
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantationOmer Jamy, Alice Chen, Kevin Battles, et al.
Blood|March 20, 2008
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cellsAnna Scuto, Mark Kirschbaum, Claudia Kowolik, et al.
Pageof 22